Harding R

Centre for Psychedelic Research, Division of Brain Sciences, Imperial College London, London, UK. rebecca.harding.22@ucl.ac.uk.

6 papers · 1 preprint · ORCID

ArticlePsilocybin

Correction: Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises.

Harding R, Singer N, Wall MB +5

Europe PMC2025
ArticlePsilocybin

Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises.

Harding R, Singer N, Wall MB +5

Europe PMC2025
ArticlePsychedelics

Neuroimaging and the Investigation of Drug-Drug Interactions Involving Psychedelics.

Wall MB, Harding R, Ertl N +6

Europe PMC2024
ArticlePsilocybin

Neuroimaging in psychedelic drug development: past, present, and future.

Wall MB, Harding R, Zafar R +3

Europe PMC2023
ArticlePsychedelics

Psychedelic therapy in the treatment of addiction: the past, present and future.

Zafar R, Siegel M, Harding R +7

Europe PMC2023
ArticlePsilocybin

Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model.

McCrone P, Fisher H, Knight C +4

Europe PMC2023
PreprintPsilocybin

Neuroimaging in psychedelic drug development: Past, present, and future

Wall M, Harding R, Zafar R +3

Europe PMC2022